Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06JFI
|
||||
Former ID |
DNC004756
|
||||
Drug Name |
ODT-8
|
||||
Indication | Discovery agent | Phase 3 | [523209] | ||
Structure |
Download2D MOL |
||||
Formula |
C54H66N10O10S2
|
||||
Canonical SMILES |
CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O<br />)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=C<br />C=CC=C5)N)C(=O)O)CC6=CC=CC=C6)O
|
||||
InChI |
1S/C54H66N10O10S2/c1-32(65)46-53(72)62-43(27-35-19-9-4-10-20-35)51(70)63-45(54(73)74)31-76-75-30-38(56)47(66)59-41(25-33-15-5-2-6-16-33)49(68)60-42(26-34-17-7-3-8-18-34)50(69)61-44(28-36-29-57-39-22-12-11-21-37(36)39)52(71)58-40(48(67)64-46)23-13-14-24-55/h2-12,15-22,29,32,38,40-46,57,65H,13-14,23-28,30-31,55-56H2,1H3,(H,58,71)(H,59,66)(H,60,68)(H,61,69)(H,62,72)(H,63,70)(H,64,67)(H,73,74)/t32-,38-,40+,41-,42+,43+,44+,45+,46-/m1/s1
|
||||
InChIKey |
PJRZZHKHLDKTKL-AYVMSDBXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 3 | Target Info | Inhibitor | [527385] | |
Somatostatin receptor type 5 | Target Info | Inhibitor | [527385] | ||
Somatostatin receptor type 2 | Target Info | Inhibitor | [527385] | ||
Somatostatin receptor type 4 | Target Info | Inhibitor | [527385] | ||
Somatostatin receptor 1 | Target Info | Inhibitor | [527385] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.